The invention relates to compounds of formula (I) for use in the prevention and/or treatment of viral infections:
Wherein X, Y, Z, T, R1a and R1b are as defined in claim 1.
Methods and compositions for treating disorders associated with cortico-hippocampal hyperactivity
申请人:RAMOT AT TEL-AVIV UNIVERSITY LTD.
公开号:US11033524B2
公开(公告)日:2021-06-15
The present invention provides pharmaceutical compositions and methods for preventing, delaying onset of, or treating diseases or disorders associated with cortico-hippocampal hyperactivity such as epilepsy, using an active agent capable of reducing dihydroorotate dehydrogenase (DHODH) enzyme activity in the central nervous system, optionally together with a pyrimidine nucleobase or an intermediate in the de novo synthesis thereof.
METHODS AND COMPOSITIONS FOR TREATING DISORDERS ASSOCIATED WITH CORTICO-HIPPOCAMPAL HYPERACTIVITY
申请人:Ramot at Tel-Aviv University Ltd.
公开号:EP3544604A1
公开(公告)日:2019-10-02
Novel Derivatives Useful as Antiviral Agents
申请人:Vidalain Pierre-Olivier
公开号:US20130210886A1
公开(公告)日:2013-08-15
The invention relates to compounds of formula (I) for use in the prevention and/or treatment of viral infections: Wherein X, Y, Z, T, R
1a
and R
1b
are as defined in claim
1
.